Curis (CRIS) Total Non-Current Liabilities (2010 - 2026)
Curis (CRIS) reported Total Non-Current Liabilities of $15.1 million for Q1 2026, up 3.99% quarter-over-quarter from $14.5 million in Q4 2025.
Curis (CRIS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Curis has reported Total Non-Current Liabilities for 17 years, with the latest figure at $15.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $15.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (changed N/A YoY), and the FY2025 full-year result was $14.5 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $15.1 million, up from $14.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $23.5 million in Q4 2023, with the low at $14.5 million in Q4 2025.
- Historically, Total Non-Current Liabilities has averaged $18.7 million across 5 years, with a median of $19.1 million in 2022.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities sank 73.36% — and 2023, when it gained 23.28%.
- Curis' Total Non-Current Liabilities stood at $19.1 million in 2022, then increased by 23.28% to $23.5 million in 2023, then retreated by 9.69% to $21.2 million in 2024, then sank by 31.69% to $14.5 million in 2025, then climbed by 3.99% to $15.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $15.1 million (Q1 2026), $14.5 million (Q4 2025), and $21.2 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 42,980.09 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 64.76 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 15.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.08 Mn |
| Dec 31, 2025 | 14.50 Mn |
| Mar 31, 2024 | 21.23 Mn |
| Dec 31, 2023 | 23.51 Mn |
| Dec 31, 2022 | 19.07 Mn |
| Dec 31, 2021 | 71.59 Mn |
| Dec 31, 2020 | 73.35 Mn |
| Dec 31, 2019 | 69.02 Mn |
| Sep 30, 2019 | 68.26 Mn |
| Jun 30, 2019 | 68.51 Mn |
| Mar 31, 2019 | 69.18 Mn |
| Dec 31, 2018 | 41.85 Mn |
| Sep 30, 2018 | 43.45 Mn |
| Jun 30, 2018 | 46.04 Mn |
| Mar 31, 2018 | 46.85 Mn |
| Dec 31, 2017 | 49.77 Mn |
| Sep 30, 2017 | 51.92 Mn |
| Jun 30, 2017 | 54.57 Mn |
| Mar 31, 2017 | 52.29 Mn |
| Dec 31, 2016 | 28.47 Mn |